Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Advisor to its Board and Chair of its R&D Committee
May 14, 2024 03:00 ET
|
Nouscom Srl
Dr. Gallagher, current President of R&D at Syndax Pharmaceuticals and former Chief Medical Officer and Head of Development at AbbVie, brings significant experience of end-to-end development that...
Cancer Vaccine Market Anticipates Robust Growth with a Projected 8.87% CAGR Through 2028
January 22, 2024 23:48 ET
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Cancer Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ResearchAndMarkets.com's...
Cancer Vaccines Market Size, Share & Growth Analysis, [2029] | With CAGR of 14.7%
December 19, 2023 05:08 ET
|
Fortune Business Insights
Pune, India, Dec. 19, 2023 (GLOBE NEWSWIRE) -- The size of the global cancer vaccines market is anticipated to increase at a CAGR of 14.7% throughout the forecast period, from USD 7.32 billion in...
Global Neoantigen Cancer Vaccine Research Report 2023: An $8.872 Billion Market by 2031 - Growing at a Staggering CAGR of 69.4%
September 27, 2023 04:28 ET
|
Research and Markets
Dublin, Sept. 27, 2023 (GLOBE NEWSWIRE) -- The "Global Neoantigen Cancer Vaccine Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering. The global...
Innovative Therapeutic Cancer Vaccines Drive Unprecedented Growth in Global Cancer Vaccines Market to 2028
September 26, 2023 08:43 ET
|
Research and Markets
Dublin, Sept. 26, 2023 (GLOBE NEWSWIRE) -- The "Cancer Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
Cancer Vaccine Market Size to Surpass Around USD 26.89 Billion by 2032
September 18, 2023 14:09 ET
|
Precedence Research
Ottawa, Sept. 18, 2023 (GLOBE NEWSWIRE) -- According to Precedence Research, the global cancer vaccine market size was valued at USD 9.12 billion in 2022. A vaccine developed for vaccine is type of...
Global Human Papillomavirus Vaccine Market Research Report 2023-2028: Breakdown of Current and Upcoming Clinical Trials with Opportunities for Growth
September 07, 2023 08:33 ET
|
Research and Markets
Dublin, Sept. 07, 2023 (GLOBE NEWSWIRE) -- The "Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Valence, By Disease...
Key Insights: Over 40 Clinical Trials for mRNA Cancer Vaccines, Phase 3 Trials Prominent; No Commercial Approvals as of August 2023
September 05, 2023 09:18 ET
|
Research and Markets
Dublin, Sept. 05, 2023 (GLOBE NEWSWIRE) -- The "Global mRNA Cancer Vaccines Market Opportunity & Clinical Pipeline Insight 2023" drug pipelines has been added to ResearchAndMarkets.com's...
Cancer Vaccines market is projected to grow at a CAGR of 14% by 2033: Visiongain
August 25, 2023 11:32 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Cancer Vaccines Market Report 2023-2033: Forecasts by Type (Preventive Vaccines, Therapeutic Vaccines), by Technology (Dendritic Cells, Recombinant,...
Cancer Vaccines Market Size to Surpass USD 19.12 Billion by 2029, exhibiting a CAGR of 14.7%
August 25, 2023 02:21 ET
|
Fortune Business Insights
Pune, India, Aug. 25, 2023 (GLOBE NEWSWIRE) -- The global cancer vaccines market size was valued at USD 6.43 billion in 2021 and is expected to grow from USD 7.32 billion in 2022 to USD 19.12...